| 发明名称 |
METHODS FOR TREATING HCV INFECTION |
| 摘要 |
The present invention provides methods of treating HCV infection in subjects (e.g., mammals), comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor or a prodrug thereof. The present invention also provides methods of treating HCV infection, comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor conjointly with at least one additional therapeutic agent (e.g., an antiviral agent). |
| 申请公布号 |
US2016101106(A1) |
申请公布日期 |
2016.04.14 |
| 申请号 |
US201414889804 |
申请日期 |
2014.05.06 |
| 申请人 |
Inhibikase Therpeutics, Inc. |
发明人 |
Werner Milton H |
| 分类号 |
A61K31/517;A61K31/44;A61K31/506;A61K31/7072;A61K31/4178;A61K31/437;A61K31/4439 |
主分类号 |
A61K31/517 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a viral infection, such as an HCV infection, in a subject in need thereof, comprising administering to the subject an effective amount of a RAF kinase inhibitor or a prodrug thereof. |
| 地址 |
Atlanta GA US |
